Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals

AIDS

Volumn 14, Issue 9, 2000, Pages 1181-1185

  Rockstroh, Jürgen K ^j   Bergmann, Frank ^a   Wiesel, Werner ^b   Rieke, Ansgar ^c   Theisen, Albert ^d   Fätkenheuer, Gerd ^e   Oette, Mark ^f   Carls, Horst ^g   Fenske, Stefan ^h   Nadler, Mathias ^k   Knechten, Heribert ⁱ  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Private Practice   (Germany)

^c Children's Hospital Kemperhof   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF COLOGNE   (Germany)

^f Krankenhaus der Augustinerinnen   (Germany)

^g Hospital Kamilianer   (Germany)

^h Private Practice   (Germany)

ⁱ Praxiszentrum   (Germany)

^j UNIVERSITY OF BONN   (Germany)

^k NONE

more..

Author keywords

Efficacy; Indinavir; Ritonavir; Safety

Indexed keywords

CD4 ANTIGEN; DIDANOSINE; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CELL COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER; THROMBOCYTOPENIA; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DIDANOSINE; DRUG ADMINISTRATION SCHEDULE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GERMANY; HIV INFECTIONS; HUMANS; INDINAVIR; LAMIVUDINE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; RNA, VIRAL; STAVUDINE; TIME FACTORS;

EID: 0033946693     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200006160-00015     Document Type: Article

References (14)

1. 1. Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. New Engl J Med 1996, 334:1011-1017.
2. 2. Gulick R, Mellors J, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiviral therapy. New Engl J Med 1997, 337:734-739.
3. 3. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. New Engl J Med 1997, 337: 725-733.
4. 4. Cameron DW, Heath-Chiozzi M, Danner S, et al. for the Advanced HIV-Disease Ritonavir Study Group. Randomized placebo controlled trial of ritonavir in advanced HIV-1 disease. Lancet 1998, 351:543-549.
5. 5. Schmid JC, Ruiz L, Clotet B et al. Resistance related mutations in the HIV-1 protease gene of patients treated for one year with the protease inhibitor ritonavir (ABT-538). AIDS 1996, 10: 995-999.
6. 6. Condra JH, Holder DJ, Schleif WA et al. Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virol 1996, 70:8270-8276.
7. 7. D'Arminio-Monforte A, Testa L, Adorni F et al. Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral experienced patients in advanced stages of HIV-1 infection. AIDS 1998, 12:1631-1637.
8. 8. Hsu A, Granneman GR, Cao G et al. Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers. Antimicrobial Agents Chemother 1998, 22:2784-2791.
9. 9. Saah AJ, Winchell G, Seniak M, Deutsch P. Multiple-dose pharmacokinetics (PK) and tolerability of indinavir (IDV)/ritonavir (RIV) combinations in healthy volunteers. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, January-February1999 [abstract 362].
10. 10. Hsu A, Grauneman GR, Heath-Chiozzi M et al. Indinavir can be given with regular meals when taken with ritonavir. XII International Conference on AIDS. Geneva June 1998 [abstract 22361].
11. 11. Fätkenheuer G, Theisen A, Rockstroh JK et al. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS 1997, 11:F113-F116.
12. 12. Kirk O, Katzenstein TL, Gerstoft J et al. Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial. AIDS 1999, 13: F9-F16.
13. 13. Staszewski S, Miller V, Sabin C et al. Determinants of sustainable CD4-lymphocyte count increases in response to antiretroviral therapy. AIDS 1999, 13:951-956.
14. 14. Boubaker K, Sudre P, Bally F et al. Changes in renal function associated with indinavir. AIDS 1998; 12:F249-254.